Historical record - last NADAC effective date: 4/17/2024
Product Information
GLIMEPIRIDE 1 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0279 per EA under NDC 16729000101. Its NADAC has been published 547 times since Nov 28, 2013.
FDA first approved this application on Aug 23, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Glimepiride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729000101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/17/2024
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078181FDA Approved
8/23/2007
TE Code
AB
On Market Since
8/23/2007
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 1 MG TABLET has been published 547 times since Nov 28, 2013, and over the history we have for it it has risen 21.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0279 per EA |
|---|---|
| All-time high | $0.0987 (Jan 13, 2016) |
| All-time low | $0.0215 (Jun 18, 2014) |
| Median price | $0.0461 |
| Average price | $0.0482 |
| Largest weekly change | +194.0% (Feb 18, 2015) |
| Weeks tracked | 547 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-0.8%
5Y
-34.3%
All
+21.3%
Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Accord Healthcare Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glimepiride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfonylurea class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 1 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0279 per EA (NDC 16729000101), effective May 15, 2024.
How has the price of GLIMEPIRIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 1 MG TABLET has risen 21.3%. It has been tracked across 547 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 1 MG TABLET?
Since Nov 28, 2013, the NADAC for GLIMEPIRIDE 1 MG TABLET has ranged from a low of $0.0215 (Jun 18, 2014) to a high of $0.0987 (Jan 13, 2016), with a median of $0.0461 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 1 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIMEPIRIDE 1 MG TABLET, is $0.0222 per EA — about 21% below GLIMEPIRIDE 1 MG TABLET.
Who manufactures GLIMEPIRIDE 1 MG TABLET?
GLIMEPIRIDE 1 MG TABLET (NDC 16729000101) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.